“…In particular, as catalyst system, a combination of Rh(acac)(cod) [acetylacetonato(1,5‐cyclooctadiene)rhodium] as the precursor and Xantphos [4,5‐bis(diphenylphosphino)‐9,9‐dimethylxanthene] as ligand has been chosen, since this system has already been reported to be active in RA [22] . This and similar catalyst systems with the solvent methanol have frequently been used in different reductive aminations and are also frequently reported in publications about hydroaminomethylation (hydroformylation with subsequent reductive amination) allowing high catalyst activities in these systems [12,13,19,20,22,23] . Moreover, Xantphos is a readily available bidentate ligand and offers the possibility of modification for more specialised applications such as catalyst recycling [23,24] .…”